
Audio By Carbonatix
Founder of the FosCel Foundation, Amos Andoh, has revealed plans by the organisation to intensify advocacy and public education on sickle cell disease, particularly in underserved communities across Ghana.
Speaking on JoyNews’ AM Show, on Monday September 29, Mr Andoh noted that despite the growing number of people living with the condition, public awareness remains alarmingly low, particularly regarding the importance of knowing one’s genotype.

“We have seen that we lack education. People are very ignorant about knowing their genotype or anything concerning sickle cell,” he stated.
The FosCel Foundation, which is headquartered in Winneba in the Central Region, is rolling out several new programmes this year, many of which are aimed at increasing understanding, reducing stigma, and improving access to medication for persons living with sickle cell.
A key highlight of these efforts is the upcoming Sickle Cell Funfair, scheduled for December 2025 at the forecourt of the Accra Mall.
“This funfair is going to unite people living with sickle cell to help clear the stigma. We’ll also partner with some pharmaceutical companies in Ghana to make access to medication easier,” Mr Andoh disclosed.
He explained that some medications used in managing the condition can be self-administered at home without a prescription, and ensuring easy access to such drugs is part of the Foundation’s broader health advocacy strategy.
Beyond raising awareness, the event is also expected to provide a platform for individuals particularly “sickle cell warriors” to share their stories, helping to normalise conversations around the condition and foster greater inclusion and empathy within families and communities.
Secretary of the Foundation, Dr Yaw Asamoah, emphasised that genotype testing should become a standard practice in relationships, in order to reduce the prevalence of sickle cell disease in Ghana.

“We want to have a society where every single one, before you say ‘I do’, you know who or what you are going in for,” Dr Asamoah stated.
He explained that the Foundation’s top priority is to ensure that every Ghanaian knows their genotype, describing it as the most effective long-term strategy to ease the burden of sickle cell on both families and the national healthcare system.
“To us, if that one is done, we think the government will have some relief not to even think of sickle cell again,” he added.
Dr Asamoah also revealed that the Foundation is advocating for sickle cell medication to be included on the National Health Insurance Authority (NHIA) list, to help ease the financial strain on affected individuals and families.
Latest Stories
-
Miracles Aboagye disputes GH¢55m claim in EOCO probe
11 minutes -
Kenneth Ashigbey denies influencing Wontumi trial, dismisses judge relationship claims as false
13 minutes -
Egyapa Mercer offers free 2026 BECE result checking support for Sekondi constituents
25 minutes -
Judges are not obliged to refer every constitutional claim to Supreme Court – Srem-Sai replies Minority
28 minutes -
I was shocked to find my name on EOCO’s stop list – Miracles Aboagye
43 minutes -
JICA is committed to strengthening laboratory capacity and biomedical research networks across Africa – JICA Ghana Chief Representative
46 minutes -
Wontumi’s defence fundamentally misunderstood the law – Deputy AG
1 hour -
I have been defamed, maligned; my wife has even packed her bags – Miracles Aboagye
1 hour -
Police arrest 10 over suspected cyber fraud, rescue 9 trafficking victims in Afienya
1 hour -
Bagbin directs MPs to comply as government bans unauthorised sirens, police escorts
2 hours -
Delegation from Dagbon informs Otumfuo of the passing of Ya-Na Abukari II
2 hours -
Five suspects arrested for alleged human trafficking in Kwabenya, 18 victims rescued
2 hours -
MTN Ghana urges households to embrace fibre broadband as home internet demand rises
2 hours -
Ipswich Town sign Abdul Fatawu from Leicester City
2 hours -
Legal battle looms in Ghana as 20-year mining conviction for Wontumi sparks constitutional debate
2 hours